| 2021-12-15 | Sale | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 28,751 0.061% | $13.00 | $373,763 | -48.8% | |
| 2021-11-16 | Sale | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 28,751 0.0619% | $15.88 | $456,532 | -54.9% | |
| 2021-04-29 | Sale | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 3,223 0.007% | $40.29 | $129,853 | -57.49% | |
| 2021-04-08 | Sale | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 100 0.0002% | $40.00 | $4,000 | -49.95% | |
| 2021-04-07 | Sale | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 1,000 0.0022% | $40.04 | $40,043 | -43.04% | |
| 2020-09-29 | Prelude Therapeutics Incorporated PRLD | EVP, Chief of Clinical Affairs | 888 0.0183% | $19.00 | $16,872 | +34.76% |